These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24351753)

  • 21. Seroprevalence for Coxiella burnetii, Francisella tularensis, Brucella abortus and Brucella melitensis in Austrian adults: a cross-sectional survey among military personnel and civilians.
    Tobudic S; Nedomansky K; Poeppl W; Müller M; Faas A; Mooseder G; Allerberger F; Stanek G; Burgmann H
    Ticks Tick Borne Dis; 2014 Apr; 5(3):315-7. PubMed ID: 24572607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Passive protection of mice against lethal Francisella tularensis (live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine.
    Drabick JJ; Narayanan RB; Williams JC; Leduc JW; Nacy CA
    Am J Med Sci; 1994 Aug; 308(2):83-7. PubMed ID: 8042659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Serum immunoglobulin IgG subclass distribution of antibody responses to Francisella tularensis in patients with tularemia].
    Rastawicki W; Rokosz-Chudziak N; Wolaniuk N
    Med Dosw Mikrobiol; 2014; 66(1):11-5. PubMed ID: 25007508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific antibodies contribute to the host protection against strains of Francisella tularensis subspecies holarctica.
    Stenmark S; Lindgren H; Tärnvik A; Sjöstedt A
    Microb Pathog; 2003 Aug; 35(2):73-80. PubMed ID: 12901846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Species- and genus-specific antigenic epitopes of Francisella tularensis lipopolysaccharides].
    Pavlovich NV; Aronova NV; Onoprienko NN; Sorokin VM; Mazrukho BL
    Mol Gen Mikrobiol Virusol; 2000; (3):7-12. PubMed ID: 10975073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoglobulin G subclass switching impacts sensitivity of an immunoassay targeting Francisella tularensis lipopolysaccharide.
    Nualnoi T; Kirosingh A; Basallo K; Hau D; Gates-Hollingsworth MA; Thorkildson P; Crump RB; Reed DE; Pandit S; AuCoin DP
    PLoS One; 2018; 13(4):e0195308. PubMed ID: 29630613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outer membrane vesicles displaying engineered glycotopes elicit protective antibodies.
    Chen L; Valentine JL; Huang CJ; Endicott CE; Moeller TD; Rasmussen JA; Fletcher JR; Boll JM; Rosenthal JA; Dobruchowska J; Wang Z; Heiss C; Azadi P; Putnam D; Trent MS; Jones BD; DeLisa MP
    Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3609-18. PubMed ID: 27274048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Agglutinins and antibodies to Francisella tularensis outer membrane antigens in the early diagnosis of disease during an outbreak of tularemia.
    Bevanger L; Maeland JA; Naess AI
    J Clin Microbiol; 1988 Mar; 26(3):433-7. PubMed ID: 3356786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel screening ELISA and a confirmatory Western blot useful for diagnosis and epidemiological studies of tularemia.
    Schmitt P; Splettstösser W; Porsch-Ozcürümez M; Finke EJ; Grunow R
    Epidemiol Infect; 2005 Aug; 133(4):759-66. PubMed ID: 16050523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of the immune response associated with tularemia: comparison of an enzyme-linked immunosorbent assay, a tube agglutination test, and a novel whole-blood lymphocyte stimulation test.
    Eliasson H; Olcén P; Sjöstedt A; Jurstrand M; Bäck E; Andersson S
    Clin Vaccine Immunol; 2008 Aug; 15(8):1238-43. PubMed ID: 18562568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Francisella tularensis Schu S4 lipopolysaccharide core sugar and O-antigen mutants are attenuated in a mouse model of tularemia.
    Rasmussen JA; Post DM; Gibson BW; Lindemann SR; Apicella MA; Meyerholz DK; Jones BD
    Infect Immun; 2014 Apr; 82(4):1523-39. PubMed ID: 24452684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis.
    Cuccui J; Thomas RM; Moule MG; D'Elia RV; Laws TR; Mills DC; Williamson D; Atkins TP; Prior JL; Wren BW
    Open Biol; 2013 May; 3(5):130002. PubMed ID: 23697804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host-adaptation of Francisella tularensis alters the bacterium's surface-carbohydrates to hinder effectors of innate and adaptive immunity.
    Zarrella TM; Singh A; Bitsaktsis C; Rahman T; Sahay B; Feustel PJ; Gosselin EJ; Sellati TJ; Hazlett KR
    PLoS One; 2011; 6(7):e22335. PubMed ID: 21799828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity.
    Sebastian S; Dillon ST; Lynch JG; Blalock LT; Balon E; Lee KT; Comstock LE; Conlan JW; Rubin EJ; Tzianabos AO; Kasper DL
    Infect Immun; 2007 May; 75(5):2591-602. PubMed ID: 17296751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen.
    Conlan JW; Shen H; Webb A; Perry MB
    Vaccine; 2002 Oct; 20(29-30):3465-71. PubMed ID: 12297391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production and characterization of monoclonal antibodies directed against the lipopolysaccharide of Francisella tularensis.
    Fulop MJ; Webber T; Manchee RJ; Kelly DC
    J Clin Microbiol; 1991 Jul; 29(7):1407-12. PubMed ID: 1885735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-mediated and humoral immune responses induced by scarification vaccination of human volunteers with a new lot of the live vaccine strain of Francisella tularensis.
    Waag DM; Galloway A; Sandstrom G; Bolt CR; England MJ; Nelson GO; Williams JC
    J Clin Microbiol; 1992 Sep; 30(9):2256-64. PubMed ID: 1400988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B-cell epitopes in GroEL of Francisella tularensis.
    Lu Z; Rynkiewicz MJ; Madico G; Li S; Yang CY; Perkins HM; Sompuram SR; Kodela V; Liu T; Morris T; Wang D; Roche MI; Seaton BA; Sharon J
    PLoS One; 2014; 9(6):e99847. PubMed ID: 24968190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of the enzyme-linked immunosorbent assay for the serodiagnosis of tularemia].
    Rastawicki W; Jagielski M; Gierczyński R
    Med Dosw Mikrobiol; 2005; 57(4):425-9. PubMed ID: 16773836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification, characterization and immunogenicity of an O-antigen capsular polysaccharide of Francisella tularensis.
    Apicella MA; Post DM; Fowler AC; Jones BD; Rasmussen JA; Hunt JR; Imagawa S; Choudhury B; Inzana TJ; Maier TM; Frank DW; Zahrt TC; Chaloner K; Jennings MP; McLendon MK; Gibson BW
    PLoS One; 2010 Jul; 5(7):e11060. PubMed ID: 20625403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.